期刊文献+

糖皮质激素在自身免疫性甲状腺疾病治疗中的选择与应用 被引量:8

The Selection and Application of Glucocorticoids in the Treatment of Utoimmune Thyroid Disease
下载PDF
导出
摘要 目的分析和研究糖皮质激素在自身免疫性甲状腺疾病治疗中的选择与应用。方法选取2011年6月至2013年4月自身免疫性甲状腺疾病患者81例,使用糖皮质激素治疗,将其治疗方法与效果进行回顾性的分析与总结。结果患者治疗后的甲状腺肿体积明显低于治疗前(P<0.05),具有统计学意义。患者治疗后的甲状腺过氧化酶抗体、甲状腺功能检测指标均优于治疗前(P<0.05),具有统计学意义。结论将糖皮质激素应用于自身免疫性甲状腺疾病患者的治疗中,能够有效控制患者的临床症状与体征,改善患者的甲状腺功能,降低其抗甲状腺自身的抗体水平值,是一种比较有效、安全、价廉的治疗方法,值得临床应用与推广。 Objective To analyze and study the selection and application of glucocorticoids in autoimmune thyroid disease.Methods From June 2011 to April 2013,81 patients with autoimmune thyroid disease were treated with glucocorticoids,the methods and effect of which were retrospectively analyzed and summarized. Results Thyroid volume of patients after treatment was significantly lower than that before treatment,with statistical significance( P〈0. 05). Thyroid peroxidase antibodies and thyroid functioned better than the status before treatment,with statistical significance( P〈0. 05). Conclusion The use of glucocorticoids in patients with autoimmune thyroid disease can effectively control the clinical symptoms and signs,improve thyroid function,and lower its own anti-thyroid antibody level. It is an effective,safe,inexpensive treatment worthy of clinical application and promotion.
出处 《辽宁医学院学报》 CAS 2015年第2期46-47,共2页 Journal of Liaoning Medical University (LNMU) Bimonthly
关键词 糖皮质激素 自身免疫性甲状腺疾病 甲状腺功能 治疗效果 glucocorticoids autoimmune thyroid disease thyroid function therapeutic effect
  • 相关文献

参考文献10

二级参考文献38

  • 1马中书,张鹏,邱明才.Graves病甲状腺功能亢进合并粒细胞减少症治疗的探讨[J].中华内科杂志,2004,43(10):781-782. 被引量:28
  • 2高莹,赵明辉,叶华,郭晓蕙.19例丙基硫氧嘧啶引起抗中性粒细胞胞浆抗体相关小血管炎的临床分析[J].中华内分泌代谢杂志,2006,22(2):124-126. 被引量:10
  • 3张洁,王邦茂,吕宗舜,刘文天,邱明才.Graves病甲亢患者慢性胃炎发病的免疫学机制[J].天津医药,2007,35(5):326-328. 被引量:8
  • 4Flaster H, Bernhagen J, Calandra, et al. The macrophage migration inhibitory factor - glucocorticoid dyad: regulation of inflammation and immunity [ J ]. Molecular Endocrinology, 2007, 21 ( 6 ) : 1267 - 1280.
  • 5Koshiyama H, Sellitti DF, Akamizu T, et al. Cardimyopathy associated with Graves'disease [J]. Clin Endocrinol, 1996, 45: 111 - 116.
  • 6Nakazawa K, Sakurai K, Hamada N, et al. Management of atrial fibrillation in the post - thyrotoxic state [J]. Am J Med, 1982, 72: 903 - 906.
  • 7Ponassi A, Morra L, Caristo G,et al. Disorders of granulopoiesis in patients with untreated Graves′ disease. Acta Haematol,1983,70:19-23.
  • 8Sheng WH,Hung CC,Chen YC,et al. Antithyroid-drug-induced agranulocytosis complicated by life threatening infections. QJM, 1999,92:455-461.
  • 9Hurtado R, Candelaria M, Majluf-Cruz A, et al. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor. Rev Invest Clin,1994,46:59-61.
  • 10Schwartz KM, Fatourechi V,Ahmed DD,et al. Dermopathy of Graves' disease (pretibial myxedema) : long-term outcome[J]. J Clin Endocrinol Metab,2002,87(2) :438 -446.

共引文献119

同被引文献34

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部